Carbiotix is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.
Read More »
Carbiotix low-cost gut health testing services are offered to consumers, companies and others as a means to cost effectively track gut health over time and overcome the natural variability associated with gut microbiome testing. The gut health tests serve as both discovery and diagnostic platform as well as assist with verifying and amplifying the efficacy of Carbiotix microbiome modulators.
View Services »
Carbiotix is developing and bringing to market a portfolio of microbiome modulators covering second generation prebiotic ingredients, medical foods and novel therapeutics. This portfolio will allow Carbiotix to leverage multiple delivery modes and industry partnerships, provide personalised microbiome modulators, and effectively address a list of leading chronic and metabolic diseases.
View Modulators »
A white label service for those interested in offering their own gut health test.
Read more »
A reliable and cost effective testing service for gut health related clinical studies.
Read more »It is the belief of Carbiotix that activity within the gut microbiome is more important than the presence of specific bacteria species. As such, the company is focused on engineering microbiome modulators to restore and optimize gut microbiome metabolic processes and thereby obtain a desired therapeutic effect through an improved metabolic profile.
Carbiotix is an award-winning public biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.
Kommuniké från extra bolagsstämma i Carbiotix AB (publ)
Carbiotix första europeiska AXOS-patent officiellt beviljat
Carbiotix first European AXOS patent is officially granted
Halvårsrapport
Delårsrapport 3
Bokslutskommuniké
Latest price:
4.855
SEK
Updated at: Sep 23, 2020, 04:40
